Suppr超能文献

新型淋巴细胞特异性CC趋化因子及其受体。

Novel lymphocyte-specific CC chemokines and their receptors.

作者信息

Yoshie O, Imai T, Nomiyama H

机构信息

Shionogi Institute for Medical Science, Osaka, Japan.

出版信息

J Leukoc Biol. 1997 Nov;62(5):634-44. doi: 10.1002/jlb.62.5.634.

Abstract

By using a cloning method termed the signal sequence trap as well as by searching for chemokine homologous sequences in the database of expressed sequence tags, cDNA fragments potentially encoding novel CC chemokines were initially identified. Using these sequences, we have cloned five novel human CC chemokines termed TARC, LARC, ELC, SLC, and PARC. These chemokines are constitutively expressed especially in some lymphoid tissues with individually unique expression patterns. The recombinant proteins are all found to be selectively chemotactic for lymphocytes but not for monocytes or neutrophils. Each chemokine appears to interact with a class of receptors on lymphocytes that is not shared by any other chemokines so far tested. Furthermore, we have identified CCR4 as the specific receptor for TARC, GPR-CY4/DRY6/CKR-L3/STRL22 as that for LARC (CCR6), and EBI1/BLR2 as that for ELC (CCR7). Only the gene for PARC is mapped to the traditional CC chemokine gene cluster at chromosome 17q11.2, whereas those for TARC, LARC, ELC, and SLC are localized at different loci. Collectively, these five CC chemokines may constitute a new category of CC chemokines that are involved in trafficking and homing of particular subsets of lymphocytes in particular lymphoid tissue microenvironments.

摘要

通过使用一种称为信号序列陷阱的克隆方法以及在表达序列标签数据库中搜索趋化因子同源序列,最初鉴定出了可能编码新型CC趋化因子的cDNA片段。利用这些序列,我们克隆了五种新型人类CC趋化因子,分别称为TARC、LARC、ELC、SLC和PARC。这些趋化因子在某些淋巴组织中持续表达,具有各自独特的表达模式。发现重组蛋白对淋巴细胞具有选择性趋化作用,而对单核细胞或中性粒细胞没有趋化作用。每种趋化因子似乎都与一类淋巴细胞上的受体相互作用,而这些受体是迄今为止测试的任何其他趋化因子所不共有的。此外,我们已确定CCR4是TARC的特异性受体,GPR-CY4/DRY6/CKR-L3/STRL22是LARC(CCR6)的特异性受体,EBI1/BLR2是ELC(CCR7)的特异性受体。只有PARC的基因定位于17q11.2染色体上的传统CC趋化因子基因簇,而TARC、LARC、ELC和SLC的基因则位于不同的位点。总的来说,这五种CC趋化因子可能构成了一类新的CC趋化因子,它们参与特定淋巴组织微环境中特定淋巴细胞亚群的迁移和归巢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验